Robot-mediated therapy for paretic upper limb of chronic patients following neurological injury.
DOI:
https://doi.org/10.2340/16501977-0403Keywords:
motor recovery, paresis, upper extremity, robotics, rehabilitation.Abstract
OBJECTIVE: To evaluate the effectiveness of robot-mediated therapy targeted at the motor recovery of the upper limb in chronic patients following neurological injury. DESIGN: Pre-post treatment study. SUBJECTS: Twenty patients were enrolled in the study. METHODS: Robot-mediated therapy was provided to chronic hemiparetic patients (acute event had occurred at least one year prior to the study), 3 times a week, for 6 weeks. The therapy consisted of goal-directed, planar reaching tasks that exercised the hemiparetic shoulder and elbow. The items for the shoulder and elbow of Motor Status Score, Modified Ashworth Scale and range of motion were used as outcome measures. RESULTS: Statistically significant improvements before and after treatment were found in each outcome measure. A 3-month follow-up evaluation indicated that patients maintained the improvements. CONCLUSION: The results confirm that robot-mediated therapy, through short-term, but intensive, repetitive and goal-directed trials, contributes to a decrease in the upper limb's motor disability in people with a chronic neurological injury by reducing motor impairment and shoulder pain. The treatment was well accepted and tolerated by patients. No adverse events occurred.Downloads
Downloads
Published
How to Cite
Issue
Section
License
All digitalized JRM contents is available freely online. The Foundation for Rehabilitation Medicine owns the copyright for all material published until volume 40 (2008), as from volume 41 (2009) authors retain copyright to their work and as from volume 49 (2017) the journal has been published Open Access, under CC-BY-NC licences (unless otherwise specified). The CC-BY-NC licenses allow third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
From 2024, articles are published under the CC-BY licence. This license permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.